U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Fill It Pack It Inc - 570946 - 07/19/2021
  1. Warning Letters

CLOSEOUT LETTER

Fill It Pack It Inc MARCS-CMS 570946 —

Delivery Method:
Via Email Delivery Confirmation
Product:
Drugs
Recipient:
Recipient Name
Mr. Robert L. Miller
Recipient Title
Vice President and Co-owner
Fill It Pack It Inc

2555 E. Del Amo Blvd.
Compton, CA 90221
United States

Issuing Office:
Division of Pharmaceutical Quality Operations IV

United States

949-608-2900

Dear Mr. Miller:

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your response to our Warning Letter (Ref CMS 570946) dated May 2, 2019. Based on our evaluation, it appears that you have adequately addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
CDR Steven E. Porter, Jr.
Director, Division of Pharmaceutical Quality Operations IV

Back to Top